Trial record 1 of 1 for:
VIP943
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06034275 |
Recruitment Status :
Recruiting
First Posted : September 13, 2023
Last Update Posted : January 12, 2024
|
Sponsor:
Vincerx Pharma, Inc.
Information provided by (Responsible Party):
Vincerx Pharma, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | May 30, 2025 |
Estimated Study Completion Date : | December 31, 2025 |